nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—esophageal cancer	0.764	1	CbGaD
Reboxetine—Sinus tachycardia—Capecitabine—esophageal cancer	0.00308	0.022	CcSEcCtD
Reboxetine—Proctalgia—Capecitabine—esophageal cancer	0.00264	0.0189	CcSEcCtD
Reboxetine—Peripheral coldness—Capecitabine—esophageal cancer	0.0026	0.0186	CcSEcCtD
Reboxetine—Anorectal disorder—Capecitabine—esophageal cancer	0.00236	0.0168	CcSEcCtD
Reboxetine—Infection—Carboplatin—esophageal cancer	0.00203	0.0145	CcSEcCtD
Reboxetine—Aphasia—Capecitabine—esophageal cancer	0.00191	0.0137	CcSEcCtD
Reboxetine—Hyperuricaemia—Cisplatin—esophageal cancer	0.00181	0.013	CcSEcCtD
Reboxetine—Nuchal rigidity—Methotrexate—esophageal cancer	0.00178	0.0127	CcSEcCtD
Reboxetine—Blood uric acid increased—Cisplatin—esophageal cancer	0.00171	0.0122	CcSEcCtD
Reboxetine—Body temperature increased—Carboplatin—esophageal cancer	0.00162	0.0116	CcSEcCtD
Reboxetine—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00154	0.011	CcSEcCtD
Reboxetine—Hypoxia—Methotrexate—esophageal cancer	0.00145	0.0104	CcSEcCtD
Reboxetine—Aphasia—Methotrexate—esophageal cancer	0.00142	0.0102	CcSEcCtD
Reboxetine—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00137	0.0098	CcSEcCtD
Reboxetine—Coordination abnormal—Capecitabine—esophageal cancer	0.00126	0.00902	CcSEcCtD
Reboxetine—Neck pain—Capecitabine—esophageal cancer	0.00125	0.00896	CcSEcCtD
Reboxetine—Hyponatraemia—Cisplatin—esophageal cancer	0.00123	0.00876	CcSEcCtD
Reboxetine—Urinary incontinence—Capecitabine—esophageal cancer	0.0012	0.00855	CcSEcCtD
Reboxetine—Face oedema—Cisplatin—esophageal cancer	0.00118	0.00842	CcSEcCtD
Reboxetine—Irritability—Cisplatin—esophageal cancer	0.00116	0.00832	CcSEcCtD
Reboxetine—Blood creatinine increased—Cisplatin—esophageal cancer	0.00114	0.00817	CcSEcCtD
Reboxetine—Dehydration—Cisplatin—esophageal cancer	0.00113	0.00811	CcSEcCtD
Reboxetine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00111	0.00797	CcSEcCtD
Reboxetine—Breast disorder—Cisplatin—esophageal cancer	0.0011	0.00788	CcSEcCtD
Reboxetine—Mental disability—Capecitabine—esophageal cancer	0.00108	0.00769	CcSEcCtD
Reboxetine—Speech disorder—Methotrexate—esophageal cancer	0.00107	0.00766	CcSEcCtD
Reboxetine—Gastroenteritis—Capecitabine—esophageal cancer	0.00101	0.00725	CcSEcCtD
Reboxetine—Glossitis—Methotrexate—esophageal cancer	0.001	0.00715	CcSEcCtD
Reboxetine—Hyperuricaemia—Methotrexate—esophageal cancer	0.000994	0.00711	CcSEcCtD
Reboxetine—Libido decreased—Capecitabine—esophageal cancer	0.00097	0.00693	CcSEcCtD
Reboxetine—Respiratory failure—Methotrexate—esophageal cancer	0.000939	0.00671	CcSEcCtD
Reboxetine—Blood uric acid increased—Methotrexate—esophageal cancer	0.000939	0.00671	CcSEcCtD
Reboxetine—Conjunctivitis—Cisplatin—esophageal cancer	0.000914	0.00653	CcSEcCtD
Reboxetine—Hyponatraemia—Capecitabine—esophageal cancer	0.000903	0.00645	CcSEcCtD
Reboxetine—Diplopia—Capecitabine—esophageal cancer	0.0009	0.00643	CcSEcCtD
Reboxetine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000892	0.00638	CcSEcCtD
Reboxetine—Face oedema—Capecitabine—esophageal cancer	0.000868	0.00621	CcSEcCtD
Reboxetine—Bradycardia—Cisplatin—esophageal cancer	0.000859	0.00614	CcSEcCtD
Reboxetine—Irritability—Capecitabine—esophageal cancer	0.000859	0.00614	CcSEcCtD
Reboxetine—Urinary retention—Capecitabine—esophageal cancer	0.000855	0.00611	CcSEcCtD
Reboxetine—Blood creatinine increased—Capecitabine—esophageal cancer	0.000843	0.00602	CcSEcCtD
Reboxetine—Dehydration—Capecitabine—esophageal cancer	0.000837	0.00598	CcSEcCtD
Reboxetine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000834	0.00596	CcSEcCtD
Reboxetine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000831	0.00594	CcSEcCtD
Reboxetine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00083	0.00593	CcSEcCtD
Reboxetine—Urethral disorder—Cisplatin—esophageal cancer	0.000828	0.00591	CcSEcCtD
Reboxetine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000822	0.00587	CcSEcCtD
Reboxetine—Visual impairment—Cisplatin—esophageal cancer	0.000814	0.00581	CcSEcCtD
Reboxetine—Breast disorder—Capecitabine—esophageal cancer	0.000813	0.00581	CcSEcCtD
Reboxetine—Muscular weakness—Capecitabine—esophageal cancer	0.000793	0.00567	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000793	0.00567	CcSEcCtD
Reboxetine—Eye disorder—Cisplatin—esophageal cancer	0.000789	0.00564	CcSEcCtD
Reboxetine—Tinnitus—Cisplatin—esophageal cancer	0.000787	0.00563	CcSEcCtD
Reboxetine—Cardiac disorder—Cisplatin—esophageal cancer	0.000784	0.0056	CcSEcCtD
Reboxetine—Influenza—Capecitabine—esophageal cancer	0.000777	0.00556	CcSEcCtD
Reboxetine—Immune system disorder—Cisplatin—esophageal cancer	0.000763	0.00545	CcSEcCtD
Reboxetine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000761	0.00544	CcSEcCtD
Reboxetine—Bronchitis—Capecitabine—esophageal cancer	0.000748	0.00534	CcSEcCtD
Reboxetine—Malnutrition—Cisplatin—esophageal cancer	0.000735	0.00525	CcSEcCtD
Reboxetine—Dysuria—Capecitabine—esophageal cancer	0.000727	0.0052	CcSEcCtD
Reboxetine—Weight decreased—Capecitabine—esophageal cancer	0.000703	0.00503	CcSEcCtD
Reboxetine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000701	0.00501	CcSEcCtD
Reboxetine—Infestation NOS—Capecitabine—esophageal cancer	0.000693	0.00495	CcSEcCtD
Reboxetine—Infestation—Capecitabine—esophageal cancer	0.000693	0.00495	CcSEcCtD
Reboxetine—Tremor—Cisplatin—esophageal cancer	0.000689	0.00492	CcSEcCtD
Reboxetine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000682	0.00487	CcSEcCtD
Reboxetine—Anaemia—Cisplatin—esophageal cancer	0.000679	0.00485	CcSEcCtD
Reboxetine—Conjunctivitis—Capecitabine—esophageal cancer	0.000674	0.00482	CcSEcCtD
Reboxetine—Urinary tract infection—Capecitabine—esophageal cancer	0.000674	0.00482	CcSEcCtD
Reboxetine—Malaise—Cisplatin—esophageal cancer	0.000663	0.00474	CcSEcCtD
Reboxetine—Leukopenia—Cisplatin—esophageal cancer	0.000658	0.0047	CcSEcCtD
Reboxetine—Epistaxis—Capecitabine—esophageal cancer	0.000654	0.00467	CcSEcCtD
Reboxetine—Irritability—Methotrexate—esophageal cancer	0.000639	0.00457	CcSEcCtD
Reboxetine—Bradycardia—Capecitabine—esophageal cancer	0.000634	0.00453	CcSEcCtD
Reboxetine—Rhinitis—Capecitabine—esophageal cancer	0.000624	0.00446	CcSEcCtD
Reboxetine—Anxiety—Cisplatin—esophageal cancer	0.000624	0.00446	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000621	0.00444	CcSEcCtD
Reboxetine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000618	0.00442	CcSEcCtD
Reboxetine—Discomfort—Cisplatin—esophageal cancer	0.000618	0.00442	CcSEcCtD
Reboxetine—Pharyngitis—Capecitabine—esophageal cancer	0.000618	0.00441	CcSEcCtD
Reboxetine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000615	0.00439	CcSEcCtD
Reboxetine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000612	0.00437	CcSEcCtD
Reboxetine—Urethral disorder—Capecitabine—esophageal cancer	0.00061	0.00436	CcSEcCtD
Reboxetine—Breast disorder—Methotrexate—esophageal cancer	0.000605	0.00432	CcSEcCtD
Reboxetine—Visual impairment—Capecitabine—esophageal cancer	0.0006	0.00429	CcSEcCtD
Reboxetine—Infection—Cisplatin—esophageal cancer	0.000596	0.00426	CcSEcCtD
Reboxetine—Nervous system disorder—Cisplatin—esophageal cancer	0.000588	0.0042	CcSEcCtD
Reboxetine—Tachycardia—Cisplatin—esophageal cancer	0.000585	0.00418	CcSEcCtD
Reboxetine—Skin disorder—Cisplatin—esophageal cancer	0.000583	0.00416	CcSEcCtD
Reboxetine—Eye disorder—Capecitabine—esophageal cancer	0.000582	0.00416	CcSEcCtD
Reboxetine—Tinnitus—Capecitabine—esophageal cancer	0.00058	0.00415	CcSEcCtD
Reboxetine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00058	0.00414	CcSEcCtD
Reboxetine—Cardiac disorder—Capecitabine—esophageal cancer	0.000578	0.00413	CcSEcCtD
Reboxetine—Anorexia—Cisplatin—esophageal cancer	0.000572	0.00409	CcSEcCtD
Reboxetine—Angiopathy—Capecitabine—esophageal cancer	0.000565	0.00403	CcSEcCtD
Reboxetine—Immune system disorder—Capecitabine—esophageal cancer	0.000562	0.00402	CcSEcCtD
Reboxetine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000561	0.00401	CcSEcCtD
Reboxetine—Hypotension—Cisplatin—esophageal cancer	0.00056	0.00401	CcSEcCtD
Reboxetine—Chills—Capecitabine—esophageal cancer	0.000558	0.00399	CcSEcCtD
Reboxetine—Mental disorder—Capecitabine—esophageal cancer	0.000545	0.0039	CcSEcCtD
Reboxetine—Malnutrition—Capecitabine—esophageal cancer	0.000542	0.00387	CcSEcCtD
Reboxetine—Dysuria—Methotrexate—esophageal cancer	0.000541	0.00387	CcSEcCtD
Reboxetine—Paraesthesia—Cisplatin—esophageal cancer	0.000539	0.00385	CcSEcCtD
Reboxetine—Dyspnoea—Cisplatin—esophageal cancer	0.000535	0.00382	CcSEcCtD
Reboxetine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000533	0.00381	CcSEcCtD
Reboxetine—Dysgeusia—Capecitabine—esophageal cancer	0.000531	0.00379	CcSEcCtD
Reboxetine—Decreased appetite—Cisplatin—esophageal cancer	0.000521	0.00373	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000518	0.0037	CcSEcCtD
Reboxetine—Infestation—Methotrexate—esophageal cancer	0.000516	0.00369	CcSEcCtD
Reboxetine—Infestation NOS—Methotrexate—esophageal cancer	0.000516	0.00369	CcSEcCtD
Reboxetine—Tremor—Capecitabine—esophageal cancer	0.000508	0.00363	CcSEcCtD
Reboxetine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000503	0.00359	CcSEcCtD
Reboxetine—Conjunctivitis—Methotrexate—esophageal cancer	0.000502	0.00358	CcSEcCtD
Reboxetine—Anaemia—Capecitabine—esophageal cancer	0.000501	0.00358	CcSEcCtD
Reboxetine—Sweating—Methotrexate—esophageal cancer	0.000495	0.00354	CcSEcCtD
Reboxetine—Feeling abnormal—Cisplatin—esophageal cancer	0.000494	0.00353	CcSEcCtD
Reboxetine—Malaise—Capecitabine—esophageal cancer	0.000489	0.00349	CcSEcCtD
Reboxetine—Epistaxis—Methotrexate—esophageal cancer	0.000487	0.00348	CcSEcCtD
Reboxetine—Vertigo—Capecitabine—esophageal cancer	0.000487	0.00348	CcSEcCtD
Reboxetine—Syncope—Capecitabine—esophageal cancer	0.000486	0.00347	CcSEcCtD
Reboxetine—Leukopenia—Capecitabine—esophageal cancer	0.000485	0.00347	CcSEcCtD
Reboxetine—Palpitations—Capecitabine—esophageal cancer	0.000479	0.00342	CcSEcCtD
Reboxetine—Loss of consciousness—Capecitabine—esophageal cancer	0.000476	0.0034	CcSEcCtD
Reboxetine—Body temperature increased—Cisplatin—esophageal cancer	0.000474	0.00339	CcSEcCtD
Reboxetine—Hypertension—Capecitabine—esophageal cancer	0.000468	0.00334	CcSEcCtD
Reboxetine—Chest pain—Capecitabine—esophageal cancer	0.000461	0.0033	CcSEcCtD
Reboxetine—Pharyngitis—Methotrexate—esophageal cancer	0.00046	0.00329	CcSEcCtD
Reboxetine—Anxiety—Capecitabine—esophageal cancer	0.00046	0.00328	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000458	0.00327	CcSEcCtD
Reboxetine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000458	0.00327	CcSEcCtD
Reboxetine—Discomfort—Capecitabine—esophageal cancer	0.000456	0.00326	CcSEcCtD
Reboxetine—Urethral disorder—Methotrexate—esophageal cancer	0.000454	0.00325	CcSEcCtD
Reboxetine—Dry mouth—Capecitabine—esophageal cancer	0.000451	0.00322	CcSEcCtD
Reboxetine—Visual impairment—Methotrexate—esophageal cancer	0.000446	0.00319	CcSEcCtD
Reboxetine—Confusional state—Capecitabine—esophageal cancer	0.000446	0.00319	CcSEcCtD
Reboxetine—Hypersensitivity—Cisplatin—esophageal cancer	0.000442	0.00316	CcSEcCtD
Reboxetine—Infection—Capecitabine—esophageal cancer	0.000439	0.00314	CcSEcCtD
Reboxetine—Shock—Capecitabine—esophageal cancer	0.000435	0.00311	CcSEcCtD
Reboxetine—Nervous system disorder—Capecitabine—esophageal cancer	0.000434	0.0031	CcSEcCtD
Reboxetine—Eye disorder—Methotrexate—esophageal cancer	0.000433	0.00309	CcSEcCtD
Reboxetine—Tinnitus—Methotrexate—esophageal cancer	0.000432	0.00309	CcSEcCtD
Reboxetine—Tachycardia—Capecitabine—esophageal cancer	0.000432	0.00308	CcSEcCtD
Reboxetine—Asthenia—Cisplatin—esophageal cancer	0.00043	0.00308	CcSEcCtD
Reboxetine—Cardiac disorder—Methotrexate—esophageal cancer	0.00043	0.00307	CcSEcCtD
Reboxetine—Skin disorder—Capecitabine—esophageal cancer	0.000429	0.00307	CcSEcCtD
Reboxetine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000427	0.00305	CcSEcCtD
Reboxetine—Anorexia—Capecitabine—esophageal cancer	0.000421	0.00301	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—esophageal cancer	0.00042	0.003	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—esophageal cancer	0.000418	0.00299	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000418	0.00298	CcSEcCtD
Reboxetine—Chills—Methotrexate—esophageal cancer	0.000416	0.00297	CcSEcCtD
Reboxetine—Hypotension—Capecitabine—esophageal cancer	0.000413	0.00295	CcSEcCtD
Reboxetine—Diarrhoea—Cisplatin—esophageal cancer	0.00041	0.00293	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—esophageal cancer	0.000406	0.0029	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—esophageal cancer	0.000403	0.00288	CcSEcCtD
Reboxetine—Insomnia—Capecitabine—esophageal cancer	0.0004	0.00286	CcSEcCtD
Reboxetine—Paraesthesia—Capecitabine—esophageal cancer	0.000397	0.00284	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—esophageal cancer	0.000395	0.00282	CcSEcCtD
Reboxetine—Dyspnoea—Capecitabine—esophageal cancer	0.000394	0.00282	CcSEcCtD
Reboxetine—Dyspepsia—Capecitabine—esophageal cancer	0.000389	0.00278	CcSEcCtD
Reboxetine—Decreased appetite—Capecitabine—esophageal cancer	0.000384	0.00275	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000382	0.00273	CcSEcCtD
Reboxetine—Vomiting—Cisplatin—esophageal cancer	0.000381	0.00273	CcSEcCtD
Reboxetine—Rash—Cisplatin—esophageal cancer	0.000378	0.0027	CcSEcCtD
Reboxetine—Constipation—Capecitabine—esophageal cancer	0.000378	0.0027	CcSEcCtD
Reboxetine—Dermatitis—Cisplatin—esophageal cancer	0.000378	0.0027	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000374	0.00267	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—esophageal cancer	0.000373	0.00266	CcSEcCtD
Reboxetine—Feeling abnormal—Capecitabine—esophageal cancer	0.000364	0.0026	CcSEcCtD
Reboxetine—Malaise—Methotrexate—esophageal cancer	0.000364	0.0026	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—esophageal cancer	0.000362	0.00259	CcSEcCtD
Reboxetine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000362	0.00258	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—esophageal cancer	0.000361	0.00258	CcSEcCtD
Reboxetine—Nausea—Cisplatin—esophageal cancer	0.000356	0.00255	CcSEcCtD
Reboxetine—Urticaria—Capecitabine—esophageal cancer	0.000351	0.00251	CcSEcCtD
Reboxetine—Abdominal pain—Capecitabine—esophageal cancer	0.00035	0.0025	CcSEcCtD
Reboxetine—Body temperature increased—Capecitabine—esophageal cancer	0.00035	0.0025	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—esophageal cancer	0.000343	0.00245	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000341	0.00244	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—esophageal cancer	0.000339	0.00242	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—esophageal cancer	0.000332	0.00237	CcSEcCtD
Reboxetine—Infection—Methotrexate—esophageal cancer	0.000327	0.00234	CcSEcCtD
Reboxetine—Hypersensitivity—Capecitabine—esophageal cancer	0.000326	0.00233	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—esophageal cancer	0.000323	0.00231	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—esophageal cancer	0.00032	0.00228	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000318	0.00227	CcSEcCtD
Reboxetine—Asthenia—Capecitabine—esophageal cancer	0.000317	0.00227	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—esophageal cancer	0.000314	0.00224	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—esophageal cancer	0.000308	0.0022	CcSEcCtD
Reboxetine—Diarrhoea—Capecitabine—esophageal cancer	0.000303	0.00216	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—esophageal cancer	0.000298	0.00213	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—esophageal cancer	0.000296	0.00211	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—esophageal cancer	0.000293	0.0021	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—esophageal cancer	0.000293	0.00209	CcSEcCtD
Reboxetine—Dizziness—Capecitabine—esophageal cancer	0.000292	0.00209	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—esophageal cancer	0.00029	0.00207	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—esophageal cancer	0.000286	0.00204	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000284	0.00203	CcSEcCtD
Reboxetine—Vomiting—Capecitabine—esophageal cancer	0.000281	0.00201	CcSEcCtD
Reboxetine—Rash—Capecitabine—esophageal cancer	0.000279	0.00199	CcSEcCtD
Reboxetine—Dermatitis—Capecitabine—esophageal cancer	0.000279	0.00199	CcSEcCtD
Reboxetine—Headache—Capecitabine—esophageal cancer	0.000277	0.00198	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—esophageal cancer	0.000271	0.00194	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000269	0.00192	CcSEcCtD
Reboxetine—Nausea—Capecitabine—esophageal cancer	0.000263	0.00188	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—esophageal cancer	0.000261	0.00187	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—esophageal cancer	0.00026	0.00186	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—esophageal cancer	0.00026	0.00186	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—esophageal cancer	0.000242	0.00173	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—esophageal cancer	0.000236	0.00169	CcSEcCtD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000233	0.00243	CbGpPWpGaD
Reboxetine—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000232	0.00242	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000229	0.00239	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000226	0.00236	CbGpPWpGaD
Reboxetine—Diarrhoea—Methotrexate—esophageal cancer	0.000225	0.00161	CcSEcCtD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000219	0.00229	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000218	0.00227	CbGpPWpGaD
Reboxetine—Dizziness—Methotrexate—esophageal cancer	0.000218	0.00156	CcSEcCtD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000214	0.00223	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.000213	0.00222	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.00021	0.00219	CbGpPWpGaD
Reboxetine—Vomiting—Methotrexate—esophageal cancer	0.000209	0.0015	CcSEcCtD
Reboxetine—Rash—Methotrexate—esophageal cancer	0.000208	0.00148	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—esophageal cancer	0.000207	0.00148	CcSEcCtD
Reboxetine—Headache—Methotrexate—esophageal cancer	0.000206	0.00147	CcSEcCtD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000202	0.00211	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000201	0.0021	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.0002	0.00208	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—NOS2—esophageal cancer	0.0002	0.00208	CbGpPWpGaD
Reboxetine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000197	0.00206	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.000196	0.00205	CbGpPWpGaD
Reboxetine—Nausea—Methotrexate—esophageal cancer	0.000196	0.0014	CcSEcCtD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000191	0.00199	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000188	0.00196	CbGpPWpGaD
Reboxetine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000185	0.00193	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000184	0.00192	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000184	0.00192	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.000183	0.0019	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00018	0.00187	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.000178	0.00185	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000174	0.00181	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.000173	0.00181	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.000171	0.00179	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—GNG7—esophageal cancer	0.00017	0.00177	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000165	0.00172	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000165	0.00172	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000163	0.0017	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000163	0.0017	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000162	0.00169	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000161	0.00168	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADCYAP1—esophageal cancer	0.000155	0.00162	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000155	0.00161	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000152	0.00159	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.00015	0.00156	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CXCL2—esophageal cancer	0.00015	0.00156	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000149	0.00156	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000148	0.00154	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000148	0.00154	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—CASP8—esophageal cancer	0.000144	0.0015	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GDI2—esophageal cancer	0.000143	0.00149	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000139	0.00145	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—ANXA1—esophageal cancer	0.000139	0.00145	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000137	0.00143	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000135	0.00141	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—SST—esophageal cancer	0.000135	0.00141	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—GHRL—esophageal cancer	0.000132	0.00137	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000132	0.00137	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00013	0.00135	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000129	0.00134	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000128	0.00134	CbGpPWpGaD
Reboxetine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.000125	0.0013	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000124	0.00129	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—EP300—esophageal cancer	0.000122	0.00127	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000122	0.00127	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00012	0.00126	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000114	0.00119	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000114	0.00118	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	0.000113	0.00117	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKAP13—esophageal cancer	0.00011	0.00115	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000109	0.00114	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000109	0.00114	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000108	0.00113	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000107	0.00111	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000106	0.0011	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000104	0.00109	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000104	0.00109	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KMT2D—esophageal cancer	0.000103	0.00107	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000101	0.00106	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PDE4D—esophageal cancer	0.000101	0.00105	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKAP13—esophageal cancer	0.0001	0.00104	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.0001	0.00104	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.94e-05	0.00104	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GNG7—esophageal cancer	9.6e-05	0.001	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	9.54e-05	0.000994	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADCYAP1—esophageal cancer	9.18e-05	0.000958	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PDE4D—esophageal cancer	9.16e-05	0.000955	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—TP53—esophageal cancer	8.73e-05	0.000911	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GNG7—esophageal cancer	8.71e-05	0.000909	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	8.6e-05	0.000897	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	8.49e-05	0.000885	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCL2—esophageal cancer	8.45e-05	0.000882	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—WWOX—esophageal cancer	8.4e-05	0.000876	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	8.09e-05	0.000844	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FKBP1A—esophageal cancer	7.99e-05	0.000833	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	7.98e-05	0.000832	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.91e-05	0.000825	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ANXA1—esophageal cancer	7.86e-05	0.00082	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—WIF1—esophageal cancer	7.81e-05	0.000814	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL2—esophageal cancer	7.68e-05	0.000801	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—SST—esophageal cancer	7.65e-05	0.000797	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GHRL—esophageal cancer	7.45e-05	0.000777	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CSNK1A1—esophageal cancer	7.21e-05	0.000751	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.18e-05	0.000749	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ANXA1—esophageal cancer	7.14e-05	0.000744	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	7.1e-05	0.00074	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	7.07e-05	0.000737	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—BLVRB—esophageal cancer	7.06e-05	0.000736	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC52A3—esophageal cancer	7.06e-05	0.000736	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—SST—esophageal cancer	6.94e-05	0.000724	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	6.83e-05	0.000712	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GHRL—esophageal cancer	6.77e-05	0.000706	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PFN1—esophageal cancer	6.74e-05	0.000703	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—BLVRB—esophageal cancer	6.65e-05	0.000693	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	6.65e-05	0.000693	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—PIK3CA—esophageal cancer	6.63e-05	0.000691	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.37e-05	0.000665	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	6.09e-05	0.000635	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ELMO1—esophageal cancer	6.05e-05	0.000631	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CA1—esophageal cancer	6e-05	0.000626	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC10A2—esophageal cancer	6e-05	0.000626	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	5.93e-05	0.000618	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.92e-05	0.000617	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKAP13—esophageal cancer	5.92e-05	0.000617	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	5.79e-05	0.000604	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CA1—esophageal cancer	5.65e-05	0.00059	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	5.65e-05	0.00059	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CA2—esophageal cancer	5.49e-05	0.000572	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HIST1H2BM—esophageal cancer	5.46e-05	0.000569	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDE4D—esophageal cancer	5.41e-05	0.000564	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.23e-05	0.000545	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CA2—esophageal cancer	5.17e-05	0.000539	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GNG7—esophageal cancer	5.15e-05	0.000537	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLCE1—esophageal cancer	5.1e-05	0.000532	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADH7—esophageal cancer	5.1e-05	0.000532	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.06e-05	0.000528	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—XIAP—esophageal cancer	4.82e-05	0.000503	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.81e-05	0.000502	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADH7—esophageal cancer	4.81e-05	0.000501	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLCE1—esophageal cancer	4.81e-05	0.000501	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CTNNA1—esophageal cancer	4.56e-05	0.000476	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL2—esophageal cancer	4.54e-05	0.000473	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADH1B—esophageal cancer	4.47e-05	0.000466	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.38e-05	0.000456	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.35e-05	0.000453	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.35e-05	0.000453	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TYMP—esophageal cancer	4.27e-05	0.000446	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PSME2—esophageal cancer	4.24e-05	0.000442	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PSME1—esophageal cancer	4.24e-05	0.000442	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ANXA1—esophageal cancer	4.22e-05	0.00044	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADH1B—esophageal cancer	4.22e-05	0.00044	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.2e-05	0.000437	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.16e-05	0.000434	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.1e-05	0.000428	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SST—esophageal cancer	4.1e-05	0.000428	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALOX15—esophageal cancer	4.05e-05	0.000423	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TYMP—esophageal cancer	4.03e-05	0.00042	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GHRL—esophageal cancer	4e-05	0.000417	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH3—esophageal cancer	4e-05	0.000417	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FBXW7—esophageal cancer	3.93e-05	0.00041	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3.92e-05	0.000409	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTO1—esophageal cancer	3.87e-05	0.000403	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TPI1—esophageal cancer	3.87e-05	0.000403	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.82e-05	0.000398	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALDOB—esophageal cancer	3.71e-05	0.000387	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CA1—esophageal cancer	3.7e-05	0.000385	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.7e-05	0.000385	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.64e-05	0.00038	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TPI1—esophageal cancer	3.64e-05	0.00038	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH2—esophageal cancer	3.59e-05	0.000374	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GAPDH—esophageal cancer	3.57e-05	0.000372	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.56e-05	0.000371	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CRABP1—esophageal cancer	3.54e-05	0.000369	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.49e-05	0.000364	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.45e-05	0.000359	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CA2—esophageal cancer	3.38e-05	0.000353	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GNG7—esophageal cancer	3.36e-05	0.000351	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.36e-05	0.000351	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.33e-05	0.000347	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFBR2—esophageal cancer	3.18e-05	0.000332	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GNG7—esophageal cancer	3.17e-05	0.000331	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALDH2—esophageal cancer	3.15e-05	0.000329	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.14e-05	0.000328	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADH7—esophageal cancer	3.14e-05	0.000328	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SMAD4—esophageal cancer	3.01e-05	0.000314	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTT1—esophageal cancer	3e-05	0.000313	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.97e-05	0.00031	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.96e-05	0.000309	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.82e-05	0.000295	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ENO1—esophageal cancer	2.81e-05	0.000293	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS1—esophageal cancer	2.81e-05	0.000293	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.81e-05	0.000293	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.79e-05	0.000291	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PSME2—esophageal cancer	2.77e-05	0.000289	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PSME1—esophageal cancer	2.77e-05	0.000289	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.76e-05	0.000287	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.65e-05	0.000276	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ENO1—esophageal cancer	2.65e-05	0.000276	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TYMP—esophageal cancer	2.63e-05	0.000275	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PSME2—esophageal cancer	2.61e-05	0.000272	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PSME1—esophageal cancer	2.61e-05	0.000272	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.56e-05	0.000267	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.5e-05	0.00026	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HIF1A—esophageal cancer	2.46e-05	0.000257	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.39e-05	0.000249	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.38e-05	0.000248	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.38e-05	0.000248	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KDR—esophageal cancer	2.36e-05	0.000246	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.28e-05	0.000238	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.25e-05	0.000235	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.25e-05	0.000234	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH1—esophageal cancer	2.22e-05	0.000231	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.2e-05	0.000229	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.18e-05	0.000227	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.12e-05	0.000221	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GNG7—esophageal cancer	2.07e-05	0.000216	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMOX1—esophageal cancer	2.05e-05	0.000214	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CREBBP—esophageal cancer	2.01e-05	0.00021	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EGFR—esophageal cancer	1.98e-05	0.000206	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.94e-05	0.000202	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.93e-05	0.000201	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CA—esophageal cancer	1.89e-05	0.000197	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.85e-05	0.000193	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.85e-05	0.000193	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.83e-05	0.00019	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOS3—esophageal cancer	1.8e-05	0.000188	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.73e-05	0.00018	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.73e-05	0.00018	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	1.72e-05	0.000179	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.71e-05	0.000178	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.71e-05	0.000178	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	1.68e-05	0.000176	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCND1—esophageal cancer	1.49e-05	0.000155	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.47e-05	0.000153	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	1.44e-05	0.00015	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.38e-05	0.000144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EP300—esophageal cancer	1.37e-05	0.000143	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CREBBP—esophageal cancer	1.31e-05	0.000137	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.26e-05	0.000132	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.24e-05	0.000129	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.21e-05	0.000126	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MYC—esophageal cancer	1.19e-05	0.000125	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NOS3—esophageal cancer	1.18e-05	0.000123	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EGFR—esophageal cancer	1.17e-05	0.000122	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NOS3—esophageal cancer	1.11e-05	0.000116	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.08e-05	0.000112	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.01e-05	0.000106	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	1.01e-05	0.000106	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TP53—esophageal cancer	9.81e-06	0.000102	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—EP300—esophageal cancer	8.95e-06	9.34e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—EP300—esophageal cancer	8.44e-06	8.8e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CREBBP—esophageal cancer	8.1e-06	8.45e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NOS3—esophageal cancer	7.25e-06	7.56e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.63e-06	6.92e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CA—esophageal cancer	6.62e-06	6.91e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	6.24e-06	6.51e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—EP300—esophageal cancer	5.52e-06	5.75e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.08e-06	4.25e-05	CbGpPWpGaD
